Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus for TSC-associated renal angiomyolipoma in China
CTR20180830Phase 4Completed
- Sponsor
- Novartis
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in kidney angiomyolipoma (AML), sponsored by Novartis. Started Jun 2018; status: completed.
02
Drugs
everolimus
03
Conditions
kidney angiomyolipoma (AML)
Beyond the preview
Go deeper on CTR20180830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180830.